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AMPLIFICATION OF THE flgE GENE PROVIDES EVIDENCE FOR THE EXISTENCE OF A  
BRAZILIAN BORRELIOSIS
Elenice MANTOVANI, Roberta G. MARANGONI, Giancarla GAUDITANO, Virgínia L.N. BONOLDI & Natalino H. YOSHINARI
SUMMARY
Introduction: The symptoms of Brazilian borreliosis resemble the clinical manifestations of Lyme disease (LD). However, 
there are differences between the two in terms of epidemiological and laboratory findings. Primers usually employed to diagnose LD 
have failed to detect Borrelia strains in Brazil. Objective: We aimed to identify the Brazilian Borrelia using a conserved gene that 
synthesizes the flagellar hook (flgE) of Borrelia burgdorferi sensu lato. Method: Three patients presenting with erythema migrans 
and positive epidemiological histories were recruited for the study. Blood samples were collected, and the DNA was extracted by 
commercial kits. Results: The gene flgE was amplified from DNA of all selected patients. Upon sequencing, these positive samples 
revealed 99% homology to B. burgdorferi flgE. Conclusion: These results support the existence of borreliosis in Brazil. However, it 
is unclear whether this borreliosis is caused by a genetically modified B. burgdorferi sensu stricto or by a new species of Borrelia spp.
KEYWORDS: Lyme disease; Lyme disease-like; Spirochaetales.
INTRODUCTION
The Brazilian borreliosis resembles the classic Lyme disease (LD) 
of North America and Eurasia with characteristics of clinical features 
including erythema migrans (EM) skin lesions6,16 and osteoarticular, 
neurological and cardiac symptoms as the bacteria disseminates27,35,36. 
However, the epidemiology and laboratory assays indicate that 
the causative agent inducing borreliosis in Brazil is different from 
commonly occurring borreliosis in North America. The ticks commonly 
associated with borreliosis to humans, Ixodes ricinus complex, have 
not been identified in regions of Brazil that possess a high incidence of 
borreliosis7,10. Borrelia burgdorferi, the LD etiological agent, was not 
present in BSK II medium cultures of patient blood samples36, ticks1,10 or 
reservoir animals in Brazil1. Moreover, specific serologic tests (ELISA 
and Western blotting), which identify antibodies to B. burgdorferi sensu 
lato of North American or European origins, have shown low sensitivity 
when applied to Brazilian patients’ samples22,26. 
Previous attempts to amplify genes specific to B. burgdorferi, 
including outer surface protein A (OspA) and genes for flagella filament 
(major flagellin FlaB, and minor flagellin FlaA), have failed in Brazilian 
samples. Ribosomal protein primers (16S rRNA) have also failed5,9. Other 
conserved genes that are necessary for Borrelia infection and survival in 
a variety of vertebrate and invertebrate hosts have also been investigated. 
The first targeted gene belonged to the cp32 plasmid group31, which was 
found to be preserved in the majority of B. burgdorferi strains. Due to 
strong homology with human DNA, gene products from cp32 could not 
be sequenced. Finally, genes encoded on lp 25 and lp 28-1,13,23 which are 
important for Borrelia virulence and infectivity, were investigated. The 
results were also negative. 
The motility and morphology of B. burgdorferi is controlled by 
periplasmic flagella located between cell cylinder and outer membrane 
sheath. This structure is composed of a basal body, a hook and a 
filament (proteins FlaA and FlaB). Recently, SAL et al. have studied the 
importance of the flagella hook in B. burgdorferi biology by targeting 
the gene that encodes the hook structural protein FlgE25. Since previous 
Molecular Biology studies had failed to identify genes codifying flagella 
proteins, the aim of the present study was to test whether PCR targeting 
flgE gene would be helpful to identify the etiological agent of Brazilian 
borreliosis. 
MATERIALS AND METHODS
Patients: We selected three patients presenting with EM between 
November 2008 and October 2009. One patient was female and two 
were male, and the mean age was 47.3 (± 28.2) years. They had a 
history of a tick bite and had visited high-risk areas in different regions 
of Brazil. All patients presented with flu-like symptoms, including fever, 
headache, myalgia, arthralgia, chills and fatigue (Table 1). All subjects 
fulfilled the Brazilian criteria for diagnosing borreliosis, as adopted by 
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the Laboratório de Investigação em Reumatologia, Hospital das Clínicas, 
Faculdade de Medicina, University of São Paulo (LIM-17), the reference 
center in Brazil16,36. 
Two patients were in the acute stage (diagnosed within three months 
of disease onset) and one was in the latent stage (diagnosed more than 
three months after disease onset) of borreliosis. The patient who was in 
the latent disease stage had developed arthritis. Two (66.6%) subjects 
had serological test results positive for B. burgdorferi G39/40 of North 
American origin, as determined by ELISA or WB according to Brazilian 
standardization18. The patient with negative serological test results was 
taking antibiotics at the time of blood sample collection (Table 2).
Thirty healthy individuals without a history of tick bite or recent 
travel to high-risk areas were included in the control group. Nineteen of 
the controls were female (63.3%) and 11 were male (36.7%). The mean 
age was 38.1 (± 22) years.
This study was approved by the Ethics Committee in Research, 
CAPPesq of the Clinical Board of the School of Medicine - University 
of São Paulo, as stated in Protocol of Research number 0895/05. All 
patients and controls provided informed written consent. 
METHODS 
DNA was extracted using the QIAamp® DNA Blood Midi Kit (Qiagen 
GmbH) from 2 mL of peripheral blood, following the manufacturer´s 
instructions.
Based on the flgE gene, one primer pair was designed using the 
Primer3 online software24. These primers were as follows: flgE 470 FW 
(5’-CGCCTATTCTAACTTGACCCGAAT - 3’) and flgE 470 Rev (5’- 
TTAGTGTTCTTGAGCTTAGAGTTG - 3’). 
Amplification was performed in a 50 µL final volume reaction 
containing 5 pmoles of each primer, 10 mM Tris-HCl, 1.5 mM MgCl2, 
1.25 mM dNTP and 1.5 U TaqDNA polymerase in DNAse/RNAse 
free H2O with 5 mL of the DNA sample. DMSO (1.5 mL) was added 
immediately before cycling (3% final concentration). 
PCR cycle conditions consisted of an initial denaturation for 3 min at 
95 ºC, and 40 repetitive cycles of 45s at 95 ºC, 45s at 64 ºC, 45s at 72 ºC, 
followed by a final extension for 7 min at 72 ºC. Good laboratory practice 
to avoid contamination was always followed, and in every reaction, we 
included one negative control to check for possible contamination. B. 
garinii was used as a positive control in all reactions. PCR products were 
eletrophoresed through a 1.5% agarose gel, stained with SYBR Gold 
(Invitrogen) and examined by UV transillumination.
Positive samples were purified with the QIAEX ® II Gel Extraction 
Kit (Qiagen GmbH), and sequencing of genomic regions was performed 
with the BigDye Terminator Cycle Sequencing kit, version 3.1 
(Applied Biosystems) and the ABI Prism 3730 DNA analyzer (Applied 
Biosystems). All sequences were examined for potential overlaps using 
the SeqManII program (DNAStar, Inc.). Prior to assembly, sequence 
ends were trimmed and primer sequences were removed manually. The 
sequences obtained were submitted for BLAST analysis to identify the 
sequences most closely related to the sample sequences2.
RESULTS
PCR targeting of the flgE gene, which amplifies a fragment of 470bp, 
yielded products in all patients evaluated (Fig. 1). The samples of the 
control group were not amplified by the primers used in this study. 
Table 1
Epidemiological and clinical characteristics of the patients with  
Brazilian borreliosis
Features Number (%) of patients
Positive epidemiologic history 3 (100)
Tick bite history 3 (100)
Flu-like symptoms 3 (100)
Erythema migrans 3 (100)
Arthritis 1 (33.3)
Arthralgia 3 (100)
Table 2
Demographic, treatment, and laboratory data of the patients with Brazilian borreliosis 
Patient Age (years) Symptoms onset (days) Treatment (days) Serology for B. burgdorferi PCR flgE
1 67 11 None Positive Positive
2 60 270 None Positive Positive
3 15 30 Tetracycline (7) Negative Positive
Fig. 1 - PCR flgE: MW = molecular weight (50bp); C+ = B. garinii; C- = control group; 1, 
2 and 3 = Brazilian borreliosis patients.
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Sequences disclosed an identity of 99% to the gene for B. burgdorferi 
flgE (L43849).
Partial sequences (flgE 470) of B. burgdorferi flgE generated in 
this study were 329 bp in length, and they were submitted to GenBank 
(accession no. HM245929). Upon comparing our sequence to the 
fragment already deposited in GenBank (L43849), which corresponds 
to the B. burgdorferi flgE gene, we could identify two different base 
substitutions (Fig. 2).
The sequence of the positive control (B. garinii) was compared with 
that of B. burgdorferi. Our positive control was 94% homologous to the 
gene for B. burgdorferi flagellar hook protein (L43849) and only 92% 
homologous to the sequence of the patients’ samples. This eliminates 
the possibility that contamination had impacted the PCR. 
DISCUSSION
Brazilian borreliosis has been investigated since 198937. Understanding 
its etiology has been a priority for Brazilian researchers. Brazilian patients 
diagnosed with Borrelia infections characteristically had a history of 
exposure to ticks, showed frequent relapsing symptoms, had low serologic 
immune response to the etiological agent of LD (B. burgdorferi sensu 
lato antigens) and contained no Borrelia species in their blood that 
were able to be identified ex vivo. In the current study, we identified the 
flgE gene in blood samples of patients diagnosed for Borrelia infection 
for the first time. Our study utilized a pair of primers derived from the 
conservative Borrelia gene flgE, which had not been previously tested 
to diagnose LD in the Northern Hemisphere. 
The flgE gene is identified in several species of Borrelia, including 
the etiological agents of relapsing fever (B. hermsii, B. duttonii, 
B. recurrentis). In this study, the comparison of our gene sequence in 
GenBank, showed that Brazilian spirochete had higher homology with 
microorganisms of B.burgdorferi sensu lato complex. 
Several cases resembling LD symptoms have been reported in 
South America, Africa and Australia3,8,14,19,21,29. However, B. burgdorferi 
had never been cultured in BSK II medium or identified by molecular 
procedures in these continents. Recently, TALHARI et al. reported the 
occurrence of Lyme borreliosis in patients from the Brazilian Amazon 
Forest32. They found spirochetes in skin biopsies of EM using specific 
immunohistochemistry and focus floating microscopy for B. burgdorferi. 
However, the authors failed to isolate and culture these microorganisms 
in BSK II medium. Also, nested PCRs targeting conserved genes were 
performed on DNA samples isolated from the biopsies and were negative. 
Therefore, molecular procedures targeting the flgE gene may provide 
additional tools for understanding zoonosis presenting with a clinical 
spectrum resembling LD. 
The flgE gene is formed of 1119 nucleotides and is responsible for 
the synthesis of the flagella hook structure15,23. The Brazilian spirochete 
Fig. 2 - Alignment comparison of sequences generated from positive samples with the gene of Borrelia burgdorferi flagellar hook protein (flgE) (L43849) performed in BLAST. Base differences 
are outlined in red. All the three positive samples sequenced presented the same base difference when compared with Borrelia burgdorferi sensu stricto sequence.
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showed consistent differences in two nucleotides bases in comparison 
with B. burgdorferi sensu stricto. This distinctive feature may serve as 
a fingerprint for Brazilian Borrelia. 
Importantly, DNA sequencing of positive samples from genus 
Rhipicephalus ticks and bovine peripheral blood demonstrated the 
same sequence pattern as seen in Brazilian patients. Their nucleotide 
alignment also showed different arrangement of two bases in comparison 
to B. burgdorferi sensu stricto sequence (unpublished data). Taken 
together, these findings reinforce the different epidemiology of Brazilian 
borreliosis from that described in LD. 
In the current study, primers for flgE were tested on samples from a 
homogenous group of patients who possessed typical EM and positive 
epidemiological characteristics. Among the three studied subjects, 
two of them were at the acute disease stage and one was at the latent 
stage, complicated with arthritis. One of three serum samples showed 
negative serological results by ELISA and WB analysis, but this patient 
had received short courses of antibiotics with her EM rashes and had 
remained seronegative, whereas the other two patients had seroconverted. 
The ability of antibiotics to block seroconversion without eliminating 
infection is well documented11,17,20.
The two patients at the acute stage of disease presented with EM 
and flu-like symptoms after a tick bite episode. The patient in the latent 
stage was a 60-year-old man (patient 2) who was infected in the Amazon 
Forest. He presented with flu-like symptoms and EM at a tick bite site, 
and he was treated with 100 mg doxycycline twice a day for 15 days. 
About eight months later, he presented with a relapsing episode of knee 
arthritis. At that time, serological tests performed for B. burgdorferi 
had positive results, and the PCR targeting the flgE gene confirmed the 
diagnosis of borreliosis.
In Brazil, patients who receive inadequate treatment at the acute stage 
or are not diagnosed until the latent stage exhibit relapsing symptoms in 
approximately 75% of the cases27,35. Delay in diagnosis or misdiagnosis 
leads to improper treatment and an unfavorable outcome. Unfortunately, 
because Brazilian physicians are not used to identifying this emerging 
zoonosis, most of the cases are diagnosed at the latent stage of the disease.
The reasons for why there are differences between LD and Brazilian 
borreliosis are still unclear. Brazilian researchers speculate that the 
etiologic agent of Brazilian borreliosis could either be a different 
Borrelia species or a genetically modified B. burgdorferi sensu stricto38. 
It is common knowledge that borreliosis can be caused by different 
species of Borrelia. Recently, STANEK & REITER30 reviewed all of 
the identified species/genospecies of Borrelia. According to the authors, 
10 years after the discovery of spirochaetes as agents of LD in 1982 in 
the United States of America, three genomic species had diverged from 
the phenotypically heterogeneous strains of B. burgdorferi that were 
isolated in North America and Europe: B. afzelii, B. burgdorferi sensu 
stricto and B. garinii. In the 1990s, another seven genospecies were 
described, including species from Asia, North America and Europe. 
From 2000 to 2010, another eight species were delineated. Of these 18 
genomic species, B. afzelii, B. burgdorferi and B. garinii are the confirmed 
agents of localized, disseminated and chronic manifestations of Lyme 
borreliosis. B. spielmanii has been detected in early skin disease, and B. 
bissettii and B. valaisiana have been detected in specimens from single 
cases of Lyme borreliosis. The clinical role of other Borrelia remains to 
be determined. Therefore, it is possible that a new “Brazilian species/
genospecies/variant” of Borrelia is circulating in Brazilian patients with 
localized, disseminated and chronic manifestations of borreliosis. In fact, 
the Brazilian geographic conditions and fauna biodiversity could have 
contributed to the development of a genetically modified spirochete, 
which is adapted to survive in the environmental conditions found in 
Brazil12,28,33,34. This would explain the distinct attributes of Brazilian 
borreliosis, as well as the difficulty of culturing the microorganism in 
BSK II medium, the low sera reactivity to B. burgdorferi and the failure 
of PCR methods using primers targeting the gene of the outer membrane 
proteins and periplasmic flagella. 
In conclusion, for the first time, we show that Brazilian borreliosis 
is caused by microorganisms possessing the flagellar hook gene (flgE), 
reinforcing the presence of a Borrelia species in the country. 
RESUMO
Amplificação do gene flgE fornece evidência para a existência de 
uma borreliose brasileira
Introdução: Os sintomas da borreliose brasileira se assemelham 
às manifestações clínicas da Doença de Lyme (DL), porém, existem 
diferenças epidemiológicas e laboratoriais entre essas enfermidades. 
Primers normalmente utilizados para diagnosticar a DL não conseguiram 
detectar cepas de borrelia no Brasil. Objetivo: O objetivo desse trabalho 
foi identificar a borrelia brasileira usando um gene conservado que 
sintetiza o gancho flagelar (flgE) da Borrelia burgdorferi sensu lato. 
Método: Três pacientes com eritema migratório e epidemiologia positiva 
foram recrutados para o estudo. Amostras de sangue foram coletadas, 
e o DNA foi extraído por kits comerciais. Resultados: O gene flgE foi 
amplificado a partir do DNA de todos os pacientes selecionados. Após o 
sequenciamento, essas amostras positivas revelaram homologia de 99% 
para B. burgdorferi. Conclusão: Estes resultados reforçam a existência 
de borreliose no Brasil. No entanto, não está claro se esta borreliose é 
causada por uma variante geneticamente modificada da B. burgdorferi 
sensu stricto ou por uma nova espécie de Borrelia spp.
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